Skip to main content

Table 1 Characteristics of the strains isolated from patients infected by nontyphoidal S. enterica

From: “Does the Salmonella Genomic Island 1 (SGI1) confer invasiveness properties to human isolates?”

Serovars SGI1-positive n (%) SGI1-negative n (%)
S. Typhimurium (n = 36) 7 (19.4) 29 (80.6)
 DT104 (n = 9) 5 (55.6) 4 (44.4)
 Non DT104 (n = 27) 2 (7.4) 25 (92.6)
Non S. Typhimurium serovars (n = 64) 5 (7.8) 59 (92.2)
S. 4, [5], 12: i- (n = 19) 0 19 (100)
S. Enteritidis (n = 14) 0 14 (100)
S. Paratyphi B var. Java (n = 2) 0 2 (100)
S. Dublin (n = 5) 0 5 (100)
 Other serovarsa (n = 24) 5b (20.8) 19 (79.2)
Phenotypesc SGI1-positive n (%) SGI1-negative n (%)
Pansusceptible (n = 21) 0 (0) 21 (100)
Resistant ≥1 (n = 79) 12 (15.2) 67 (84.8)
Including penta-resistant (ACSSuT)d (n = 9) 6 (67) 3 (33)
  1. aOther serovars (n = 24): S. Ahmadi (n = 1). S. Braenderup (n = 1). S. Chester (n = 2). S. Eastbourne (n = 1). S. Eboko (n = 1). S. Hadar (n = 1). S. Hessarek (n = 2); S. Infantis (n = 2); S. Kedougou (n = 1); S. Kentucky (n = 2); S. Napoli (n = 1); S. Panama (n = 1); S. Rissen (n = 1); S. Schwarzengrund (n = 2); S. Singapore (n = 1); S. St Paul (n = 3); and a new variant: 6, 7, − (n = 1)
  2. bOther serovars with SGI1 (n = 5): S. Infantis (n = 1), S. Kentucky (n = 2), S. St Paul (n = 2)
  3. cPhenotype was determined by testing amoxicillin, amoxicillin – clavulanic acid, ceftriaxone, nalidixic acid, chloramphenicol, kanamycin, spectinomycin, streptomycin, sulphonamides, trimethoprim and doxycycline in accordance to the antibiomicrobial guidelines of CASFM- EUCAST
  4. dACSSuT: Amoxicillin, Chloramphenicol, Streptomycin, Sulphonamides and Tetracyclines